Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 16.1T | 17.6T | 15.9T | 15.2T |
Cost of revenue | 9.8T | 11.1T | 9.7T | 9.6T |
Gross profit | 6.3T | 6.5T | 6.2T | 5.7T |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 3.7T | 3.4T | 3.4T | 3.3T |
Other operating expenses | — | — | — | — |
Operating income | 2.6T | 3.1T | 2.8T | 2.3T |
Non operating interest income | ||||
Income | 349.8B | 576.4B | 326.7B | 569.3B |
Expense | 152.4B | 134.9B | 128.8B | 150.1B |
Other income expense | — | — | — | — |
Pretax income | 3.0T | 3.0T | 2.9T | 2.7T |
Tax provision | 429.1B | 466.2B | 430.0B | 381.3B |
Net income | 2.6T | 2.5T | 2.5T | 2.3T |
Basic EPS | 147.8 | 99.4 | 143 | 109.8 |
Diluted EPS | 147.8 | 99.4 | 143 | 109.8 |
Basic average shares | 14.7B | 14.7B | 14.6B | 17.1B |
Diluted average shares | 14.7B | 14.7B | 14.6B | 17.1B |
EBITDA | 3.9T | 3.7T | 3.7T | 3.4T |
Net income from continuing op. | 3.0T | 3.0T | 2.9T | 2.7T |
Minority interests | -421.3B | -406.5B | -389.7B | -409.2B |
Preferred stock dividends | 0 | 0 | 0 | 0 |